BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 38309149)

  • 1. Generation of two hiPSCs lines of two patients carrying truncating mutations in the dimerization domain of filamin C.
    Daya NM; Döring K; Zhuge H; Volke L; Stab V; Dietz J; Athamneh M; Roos A; Zaehres H; Güttsches AK; Mavrommatis L; Vorgerd M
    Stem Cell Res; 2024 Apr; 76():103320. PubMed ID: 38309149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of a human iPSC line (HIMRi001-A) from a patient with filaminopathy.
    Daya NM; Mavrommatis L; Zhuge H; Athamneh M; Roos A; Gläser D; Doering K; Zaehres H; Vorgerd M; Güttsches AK
    Stem Cell Res; 2023 Oct; 72():103210. PubMed ID: 37748332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of two human iPSC lines (HIMRi002-A and HIMRi003-A) derived from Caveolinopathy patients with rippling muscle disease.
    Boeing A; Mavrommatis L; Daya NM; Zhuge H; Volke L; Kocabas A; Kneifel M; Athamneh M; Krause K; Südkamp N; Döring K; Theiss C; Roos A; Zaehres H; Güttsches AK; Vorgerd M
    Stem Cell Res; 2023 Oct; 72():103220. PubMed ID: 37839261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of the human induced pluripotent stem cell line PUMCi005-A from a patient with Perrault syndrome.
    Wang YB; Lv YF; Zhang Y; Wang W
    Stem Cell Res; 2024 Mar; 75():103318. PubMed ID: 38295749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of two induced pluripotent stem cell lines from dilated cardiomyopathy patients carrying heterozygous FLNC mutations.
    Kojic A; Kim H; Guevara JV; Ravada S; Sallam K; Wu JC
    Stem Cell Res; 2022 Oct; 64():102928. PubMed ID: 36194907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of two induced pluripotent stem cells lines from a Mucopolysaccharydosis IIIB (MPSIIIB) patient.
    Vallejo-Diez S; Fleischer A; Martín-Fernández JM; Sánchez-Gilabert A; Bachiller D
    Stem Cell Res; 2018 Dec; 33():180-184. PubMed ID: 30408744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation and characterization of iPS cell line (CTGUi001-A) from skin fibroblasts of a patient with Fabry disease.
    Qin Y; Zhan JQ; Ma CJ; Cao CY; Zhang Y; Min YT; Lv YF
    Stem Cell Res; 2023 Jun; 69():103063. PubMed ID: 36917862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of induced pluripotent stem cell line NIMHi010-A from dermal fibroblast cells of a healthy individual.
    Dash SS; Arunachal G; Nimonkar MM; Vengalil S; Nashi S; Chetan GK; Boddu VK; Nalini A; Markandeya YS
    Stem Cell Res; 2024 Apr; 76():103355. PubMed ID: 38412659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of two induced pluripotent stem cell lines from a retinitis pigmentosa patient with compound heterozygous mutations in CRB1.
    Moon SY; Zhang D; Chen SC; Lamey TM; Thompson JA; McLaren TL; De Roach JN; Chen FK; McLenachan S
    Stem Cell Res; 2021 Jul; 54():102403. PubMed ID: 34034222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Establishment of two hiPSC lines (IIMCBi001-A and IIMCBi002-A) from dermal fibroblasts of healthy donors and characterization of their cell cycle.
    Liszewska E; Majchrowicz L; Krogulec E; Kotulska K; Kaczmarek L; Kalita K; Dobrzyń A; Jaworski J
    Stem Cell Res; 2021 Apr; 52():102225. PubMed ID: 33588215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of induced pluripotent stem cell line (RCMGi012-A) from fibroblasts of patient with mucopolysaccharidosis type VI.
    Kondrateva E; Grigorieva O; Panchuk I; Bychkov I; Zakharova E; Tabakov V; Pozhitnova V; Voronina E; Shchagina O; Lavrov A; Smirnikhina S; Kutsev S
    Stem Cell Res; 2023 Dec; 73():103259. PubMed ID: 38006675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Homozygous expression of the myofibrillar myopathy-associated p.W2710X filamin C variant reveals major pathomechanisms of sarcomeric lesion formation.
    Schuld J; Orfanos Z; Chevessier F; Eggers B; Heil L; Uszkoreit J; Unger A; Kirfel G; van der Ven PFM; Marcus K; Linke WA; Clemen CS; Schröder R; Fürst DO
    Acta Neuropathol Commun; 2020 Sep; 8(1):154. PubMed ID: 32887649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of a heterozygous FLNC mutation-carrying human iPSC line, USFi002-A, for modeling dilated cardiomyopathy.
    Argenziano MA; Burgos Angulo M; Najari Beidokhti M; Yang J; Bertalovitz AC; McDonald TV
    Stem Cell Res; 2021 May; 53():102394. PubMed ID: 34088019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of two human iPSC lines (MDCUi001-A and MDCUi001-B) from dermal fibroblasts of a Thai patient with X-linked osteogenesis imperfecta using integration-free Sendai virus.
    Tongkobpetch S; Rungsiwiwut R; Pruksananonda K; Suphapeetiporn K; Shotelersuk V
    Stem Cell Res; 2019 Aug; 39():101493. PubMed ID: 31326747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An induced pluripotent stem cell line (CSUi004-A) from skin fibroblasts of a healthy individual.
    Wang L; Zhao H; Wu J; Ren J; Luo H; Zuo X; Chen Q; Tang Y
    Stem Cell Res; 2021 May; 53():102336. PubMed ID: 33865102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation of induced pluripotent stem cells (iPSCs) from an infant with catecholaminergic polymorphic ventricular tachycardia carrying the double heterozygous mutations A1855D in RyR2 and Q1362H in SCN10A.
    Zhang Y; Li A; Huang CL; Wang G; Wang D
    Stem Cell Res; 2019 Aug; 39():101509. PubMed ID: 31382203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Establishment of an induced pluripotent stem cell line (CSUi003-A) from fibroblasts of a healthy elderly individual.
    Zhao H; Wang L; Wu J; Ren J; Chen Q; Luo H; Zuo X; Tang Y
    Stem Cell Res; 2021 May; 53():102326. PubMed ID: 33845242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of a human iPSC line (MPIi008-A) from a patient with Denys-Drash syndrome.
    Doeser MC; Krygin J; Röpke A; Han D; Wedlich-Söldner R; Schöler HR; Pavenstädt H; Kim KP
    Stem Cell Res; 2022 Jul; 62():102826. PubMed ID: 35667217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of an induced pluripotent stem cell line (SDASi001-A) from a Schimke immune-osseous dysplasia patient with SMARCAL1 mutations.
    Wang X; Zhang H; Wang X; Zhou W; Dong L; Li N; He Q
    Stem Cell Res; 2023 Oct; 72():103217. PubMed ID: 37788557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of iPSC lines from peripheral blood mononuclear cells from five healthy donors.
    Vlahos K; Sourris K; Yi Kuah J; Graham A; Suter A; Howden SE; Stanley EG; Elefanty AG
    Stem Cell Res; 2023 Jun; 69():103109. PubMed ID: 37150143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.